Loading...
OTCM
BSYXF
Market cap146mUSD
, Last price  
USD
Name

Biosynex SA

Chart & performance

D1W1MN
OTCM:BSYXF chart
P/E
P/S
EPS
Div yield, %
Shrs. gr., 5y
Rev. gr., 5y
42.61%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Biosynex S.A. specializes in the development, manufacture, and worldwide distribution of rapid diagnostic solutions. Their extensive product line includes a variety of quick diagnostic assays, immunoblots, molecular biology tools, and point-of-care devices. These offerings are vital for screening, diagnosis, and prevention across numerous medical fields, such as bacteriology, parasitology, mycology, virology, biochemistry, oncology, and women's health, alongside specific COVID-19 tests and related instruments. Additionally, Biosynex provides consumer products like self-testing kits, personal health monitoring equipment (including thermometers and blood pressure monitors), and a selection of oral care and medical aid supplies. The company serves a diverse client base, including biological and medical analysis laboratories, hospitals, pharmacies, and large retail outlets like hypermarkets and supermarkets. Founded in 1993, Biosynex S.A. is headquartered in Illkirch-Graffenstaden, France.
IPO date
Mar 21, 2011
Employees
367
Domiciled in
FR
Incorporated in
FR

Valuation

No data to show